From Pharmacogenetics to Gene Expression: Implications for Precision Medicine in Diabetes
Approximately 25–60% of patients show specific pharmacological responses to a particular drug. We call this interindividual variability (IV) response to drugs affecting their efficacy and the appearance of side effects in individuals. This IV may be due to multifactorial components such as genetic f...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76348 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: From Pharmacogenetics to Gene Expression: Implications for Precision Medicine in Diabetes
- Pharmacogenetics for T2DM and Anti-Diabetic Drugs
- The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications
- Introductory Chapter: Integrating Pharmacokinetics and Pharmacogenetics in the Era of Personalized Medicine
- Pharmacogenetics and Pharmacogenomics of Colorectal Cancer: Moving Towards Personalized Medicine
- Pharmacogenetics of Metformin in Type 2 Diabetes: Perspectives for Latin America
- Pharmacogenetics: Matching the Right Foundation at Personalized Medicine in the Right Genomic Era